NorthWest Biotherapeutics Inc (NWBO)

[georgebailey]

Antihama I read the rules a couple months ago- the MHRA position IMO was describing a strong preference for applicants to remain quiet unless status PRs were in the public interest, unmet need…etc.thats in writing.
So the applicants were never prohibited.
As far as MHRA not discouraging PR’s that’s a nice friendly statement but i think generally speaking the MHRA doesn’t want to get bombarded, pressured resulting from applicant PR’s.Applicant PR’s I suppose can be fine but God knows how they get interpreted by the public and how many questions these PRs create for MHRA.
You speak of the average investor having to guess- this isn’t about just the investor, it’s about the MHRA as An organization operating in an acceptable environment to process applications and it’s about patients…so it’s complicated. I can think this stuff but it’s not the same as having GbM and wondering where DCVax is in the process so the patient has a chance to live- I think Powers made PR decisions on status with all these factors in mind.